Aphria Inc. (APHA)
(Delayed Data from NYSE)
$6.94 USD
-0.19 (-2.66%)
Updated May 3, 2019 04:02 PM ET
After-Market: $7.00 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.94 USD
-0.19 (-2.66%)
Updated May 3, 2019 04:02 PM ET
After-Market: $7.00 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Myriad Genetics Test to Identify Cancer Patients Gets FDA Nod
by Zacks Equity Research
Myriad Genetics (MYGN) moves a step toward advanced treatment by identifying women with ovarian cancer, who are currently receiving chemotherapy.
Aphria Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Aphria has been struggling lately, but the selling pressure may be coming to an end soon.
Here's Why You Should Hold on to Abbott (ABT) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Abbott's (ABT) performance.
ResMed Upgrades Nasal Care by Introducing Cradle CPAP Mask
by Zacks Equity Research
ResMed (RMD) revolutionizes sleep apnea treatment by introducing a hassle-free and easy-to-use mask.
Medical Products Industry Outlook: Prospects Seem Promising
by Trina Mukherjee
Growth prospects look bright for the Zacks Medical Products industry, thanks to AI, Medical Mechatronics and Robotics and rampant M&As.
Aphria Inc. (APHA) Reports Break-Even Earnings for Q1
by Zacks Equity Research
Aphria Inc. (APHA) delivered earnings and revenue surprises of 100.00% and -7.05%, respectively, for the quarter ended August 2019. Do the numbers hold clues to what lies ahead for the stock?
Aphria Inc. (APHA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed at $4.70 in the latest trading session, marking a +1.82% move from the prior day.
Analysts Estimate Aphria Inc. (APHA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Aphria Inc. (APHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aphria Inc. (APHA) Upgraded to Buy: Here's Why
by Zacks Equity Research
Aphria Inc. (APHA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Aphria Inc. (APHA) Flat As Market Gains: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed the most recent trading day at $5.36, making no change from the previous trading session.
Implied Volatility Surging for Aphria (APHA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Aphria (APHA) stock based on the movements in the options market lately.
The Zacks Analyst Blog Highlights: Anheuser-Busch, Tilray, Boston Beer, Constellation Brands and Aphria
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Anheuser-Busch, Tilray, Boston Beer, Constellation Brands and Aphria
4 Stocks to Ride on the CBD-Infused Beverage Trend
by Zacks Equity Research
CBD-infused drinks are gaining fast popularity among all age groups, thanks to its many health benefits.
Aphria Inc. (APHA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed the most recent trading day at $6.24, moving +0.97% from the previous trading session.
ETFs in Focus as Consolidation Drives Marijuana Industry
by Sanghamitra Saha
Deals activity has been robust in the marijuana space, paving way for gains in these cannabis ETFs.
Aphria Inc. (APHA) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Aphria Inc. (APHA).
Company News For Aug 5, 2019
by Zacks Equity Research
Companies in the news are: XOM, NWL, QSR and APHA
Implied Volatility Surging for Aphria (APHA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Aphria (APHA) stock based on the movements in the options market lately.
Earnings Preview: Aphria Inc. (APHA) Q4 Earnings Expected to Decline
by Zacks Equity Research
Aphria Inc. (APHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aphria Inc. (APHA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Aphria Inc. (APHA) closed at $6.98, marking a +0.87% move from the previous day.
Aphria Inc. (APHA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aphria Inc. (APHA) closed at $6.87, marking a +1.18% move from the previous day.
Implied Volatility Surging for Aphria (APHA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Aphria (APHA) stock based on the movements in the options market lately.
Marijuana Stocks & ETFs: What Investors Need to Know
by Neena Mishra
Here is what investors need to know about cannabis investing and the first actively managed pot ETF.
New Strong Sell Stocks for April 23rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Likely Canopy-Acreage Deal Looks Good Enough to Boost ETF MJ
by Sanghamitra Saha
Canopy Growth will probably purchase the rights to buy Acreage Holdings to tap the growing potential of the U.S. marijuana market. This should bolster the ETF MJ.